![](/img/cover-not-exists.png)
MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2
Chen, Ming-Jenn, Wu, De-Wei, Wang, Gao-Chang, Wang, Yao-Chen, Chen, Chi-Yi, Lee, HueiVolume:
9
Language:
english
Journal:
Oncotarget
DOI:
10.18632/oncotarget.24474
Date:
March, 2018
File:
PDF, 2.83 MB
english, 2018